PL3326619T3 - Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę - Google Patents

Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę

Info

Publication number
PL3326619T3
PL3326619T3 PL17203972T PL17203972T PL3326619T3 PL 3326619 T3 PL3326619 T3 PL 3326619T3 PL 17203972 T PL17203972 T PL 17203972T PL 17203972 T PL17203972 T PL 17203972T PL 3326619 T3 PL3326619 T3 PL 3326619T3
Authority
PL
Poland
Prior art keywords
emtricitabine
tenofovir
pharmaceutical compositions
solid oral
oral pharmaceutical
Prior art date
Application number
PL17203972T
Other languages
English (en)
Inventor
Ali TÜRKYILMAZ
Ediz Yildirim
Bülent Demir
Yesim MURATOGLU
Ayda NURIOGLU
Oguz Bas
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret A.S. filed Critical Sanovel Ilac Sanayi Ve Ticaret A.S.
Publication of PL3326619T3 publication Critical patent/PL3326619T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17203972T 2016-11-29 2017-11-28 Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę PL3326619T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2016/17448A TR201617448A2 (tr) 2016-11-29 2016-11-29 Tenofovi̇r ve emtri̇si̇tabi̇n i̇çeren kati oral farmasöti̇k bi̇leşi̇mler
EP17203972.9A EP3326619B1 (en) 2016-11-29 2017-11-28 Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine

Publications (1)

Publication Number Publication Date
PL3326619T3 true PL3326619T3 (pl) 2022-06-06

Family

ID=60569617

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17203972T PL3326619T3 (pl) 2016-11-29 2017-11-28 Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę

Country Status (7)

Country Link
EP (1) EP3326619B1 (pl)
EA (1) EA201991286A1 (pl)
ES (1) ES2910924T3 (pl)
PL (1) PL3326619T3 (pl)
PT (1) PT3326619T (pl)
TR (1) TR201617448A2 (pl)
WO (1) WO2018099895A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021091498A1 (en) * 2019-11-06 2021-05-14 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising tenofovir and emtricitabine
CN112274488B (zh) * 2020-10-22 2022-08-26 安徽贝克生物制药有限公司 一种恩曲他滨、替诺福韦复方片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398455T1 (de) * 2003-01-14 2008-07-15 Gilead Sciences Inc Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
SI2051703T1 (sl) 2005-12-14 2011-01-31 Cipla Ltd Farmacevtski sestavki, ki vsebujejo inhibitorje nukleotidne in nukleozidne reverzne transkriptaze (kot tenofovir in lamivudin) v različnih delih dozirne oblike
WO2008096369A2 (en) * 2007-02-05 2008-08-14 Matrix Laboratories Limited Pharmaceutical formulation for use in hiv therapy
EP2365798A2 (en) * 2008-11-21 2011-09-21 Ultimorphix Technologies B.v. Wet granulation of tenofovir, emtricitabine and efavirenz
ME01980B (me) * 2010-11-19 2015-05-20 Gilead Sciences Inc Terapeutske kompozicije koje sadrže rilpivirin hcl i tenofovir dizoproksil fumarat
KR20140119012A (ko) * 2013-01-31 2014-10-08 길리어드 파마셋 엘엘씨 두 항바이러스 화합물의 병용 제형물
US20160199396A1 (en) * 2013-08-29 2016-07-14 Teva Pharmaceutical Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
IN2013CH05288A (pl) * 2013-11-18 2015-09-11 Aurobindo Pharma Ltd
CZ2013985A3 (cs) 2013-12-09 2015-06-17 Zentiva, K.S. Stabilní farmaceutická kompozice obsahující tenofovir disoproxil fumarát

Also Published As

Publication number Publication date
TR201617448A2 (tr) 2018-06-21
EA201991286A1 (ru) 2019-10-31
PT3326619T (pt) 2022-03-25
ES2910924T3 (es) 2022-05-17
EP3326619B1 (en) 2022-01-05
WO2018099895A1 (en) 2018-06-07
EP3326619A1 (en) 2018-05-30

Similar Documents

Publication Publication Date Title
HK1248547A1 (zh) 包含替諾福韋和恩曲他濱的藥物製劑
IL262495B (en) History of isoquinolin-3-yl carboxamide and pharmaceutical preparations containing them
GB201620066D0 (en) Solid Pharmaceutical dosage formulations and processes
ZA201900275B (en) Oral gastroretentive formulations and uses thereof
IL266522A (en) Pharmaceutical compositions
HK1248544A1 (zh) 穩定的口服給藥用藥物組合物
HK1245113A1 (zh) 藥物組合物及其用途
PL3145508T3 (pl) Nanocząstki klewidypiny i ich kompozycje farmaceutyczne
HK1245646A1 (zh) 口服給藥用醫藥組合物
IL279877A (en) Ibusidanib forms and pharmaceutical preparations
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
PT3326619T (pt) Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina
IL254711B (en) History of diazepine-indole and medicinal preparations containing them
IL271908A (en) Over-compressed pharmaceutical preparations
ZA201903341B (en) Pharmaceutical compositions and uses thereof
GB2569616B (en) Sustained release oral pharmaceutical compositions of dicycloverine
EP3560492C0 (en) COMPOSITION OF LIPID PARTICLES AND PHARMACEUTICAL COMPOSITION
GB201812022D0 (en) Pharmaceutical methods and compositions
GB201713920D0 (en) Pharmaceutical compositions and uses thereof
GB201604810D0 (en) Pharmaceutical compositions and uses
GB201610440D0 (en) Pharmaceutical formulations
AU2015901459A0 (en) Pharmaceutical powder composition and use